0% found this document useful (0 votes)
73 views16 pages

' Respiratory Disorders

Uploaded by

ebp817
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
73 views16 pages

' Respiratory Disorders

Uploaded by

ebp817
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 16

NU 102 Exam 2 Study Guide

Respiratory Disorders
By Mary Joyce Caballes

✰​Respiratory Tract Disorders​✰


KUFEAGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGGFGGGGGGGGGGGGGGGGGGGGG

✰​ Atelectasis ​= ​closure or collapse of alveoli; causes reduced alveolar ventilation


● Can be acute or chronic
○ Acute more common.

● Types:
○ Microatelectasis​ =​ not detectable​ on chest x-rays
○ Macroatelectasis​ = loss of segment, lobar, or overall lung volume
● Causes:
○ Postop:
■ Specific surgical procedures (ex: upper abdominal, thoracic, or open heart surgery)
■ High risk due to monotonous, low tidal breathing pattern which can cause small airway closure and alveolar collapse. This can be
from:
● Shallow respirations, pain, splinting, anesthesia, analgesics, supine position
○ Immobilization
○ Excessive excretions
○ Chronic airway obstruction by secretions from due to impaired cough mechanism or conditions that restrict normal lung expansion on inspiration
(ex: lung cancer)
○ Hypoventilation
○ ↑ abdominal pressure
○ Musculoskeletal or neurological disorders
○ Pressure on lung tissue:
■ Pleural effusion = fluid in pleural space
■ Pneumothorax = air in pleural space
■ Hemothorax = blood in pleural space
■ Elevated diaphragm (abdominal distension)
● Risk Factors:
○ Older age
○ Preexisting resp conditions; COPD
○ Heart failure
○ ↓ level of consciousness
○ Poor functional ability/immobility
○ History of cigarette smoking
○ Malnutrition
● Symptoms:
○ Dyspnea Acute: Chronic:​ (same as acute)
○ Cough • Respiratory distress • Predispose pt’s to pulmonary infections
○ Sputum production • Tachycardia
○ Hypoxemia • Pleural Pain
○ Fever - low grade • Central cyanosis (late sign)
• Difficulty breathing in supine
• anxious
● Assessment & Dx Tests:
○ ↑ breathing
○ Hypoxia (SpO2 <90%)
○ ↓ breath sounds and crackles are heard over the affected area
■ Crackles heard in dependent posterior area of lungs
○ Chest x ray may show atelectasis (​patchy​ infiltrates or​ consolidated ​areas) before symptoms appear
● Prevention/Interventions:
○ Frequent turning from supine to upright
○ Early mobilization from bed to chair followed by early ambulation
○ Expand the lungs:
■ Deep breathing exercises = every 2 hours
■ Incentive spirometer
○ Manage Secretions:
■ Deep breathing and cough
■ Suctioning prn
■ Aerosol nebulizer
■ Chest physiotherapy
● Postural drainage
● Chest percussion
■ Bronchoscopy
○ ICOUGH Program:
■ I​ncentive spirometry
■ C​oughing and deep breathing
■ O​ral care (brushing teeth and using mouthwash 2x a day)
■ U​nderstanding (pt and staff education)
■ G​etting out of bed at least 3x daily
■ H​ead of bed elevation
● Treatment/Management:
○ Bronchodilators
■ Nebulizer treatments or MDI
○ Positive end-expiratory pressure (PEEP) = a simple mask and one-way valve system that provides varying amounts of expiratory resistance,
usually 10-15 cm H2O may be needed if pt can’t perform deep breathing exercises.
○ Thoracentesis = removal of fluid by needle aspiration
○ Insertion of chest tube

✰​ Pneumonia (PNA) ​=​ acute infection causing inflammation of lung parenchyma (bronchioles and alveolar spaces)
in one or both lungs caused by various organisms like bacteria, viruses, and fungi.
❖ Air sacs may fill will fluid, mucus, or pus = limits amount of O2 entering sacs
❖ Most serious in infants, young children, 65+, and co-morbidities or weakened immune systems

● Types:
○ Community-acquired pneumonia​ (CAP) = acquired outside hospitals or extended care facilities
○ Hospital-acquired pneumonia​ (HAP) = contracted by pt in hospital at least 48-72 hours after being admitted
■ Presented with a new pulmonary infiltrate on chest x-ray combined with evidence of infection such as fever, respiratory symptoms,
purulent sputum, or leukocytosis.
○ Health Care-associated pneumonia​ (HCAP) = contracted in other health care settings like nursing homes, dialysis centers, and outpatient
clinics
○ Aspiration pneumonia​ = occurs if food, drink, vomit, or saliva is inhaled from mouth to lungs
● Causes:
○ Bacteria = streptococcus pneumoniae
■ **most common cause
■ Usually happens to elderly pt’s 65+
○ Bacteria like organisms = mycoplasma pneumoniae
■ Produces milder symptoms
■ Walking pneumonia = asymptomatic, a typical pneumonia
○ Fungi
■ Common in people with weakened immune system/chronic health problems
■ Fungi found in soil or bird droppings
○ Viruses
■ Cold and flu can cause pneumonia
■ Usually mild, but can become very serious
■ RSV = virus that causes infection of lungs and respiratory tract
● So common that most children have been affected by age 2
■ Human rhinovirus = most common viral infection, common cold
■ Viral pneumonia can lead to bacterial pneumonia
● Risk Factors:
○ Age 65+
○ Alcoholism
○ Beta-lactam therapy (ex: cephalosporins) in past 3 months
○ Multiple medical comorbidities
○ Weakened or suppressed immune system (ex: HIV) or underlying cardiopulmonary disease
○ Residency in long-term care facility
○ Corticosteroid therapy
○ Malnutrition
○ Cigarette smoking
○ Exposure to chemicals, pollutants, toxic fumes
○ History of lung disease or other serious disease
○ Limited mobility
● Symptoms:
○ Sudden onset of chills and fever
○ Productive cough or rust colored or purulent sputum = viral dry cough
○ Use of accessory muscles
○ Pleuritic pain = chest pain with cough or breaths
○ ↓ breath sounds, fine ​crackles, rhonchi, wheezes, bronchial breath sounds
○ Nasal flaring
○ Fatigue
○ Lower than normal body temp
○ SOB, dyspnea, tachypnea
○ Cyanosis if air exchange is impaired
○ Confusion or changes in mental status
○ Nausea, vomiting, or diarrhea
○ Older and debilitated pts may be atypical; s&s may be absent or misleading
■ Little resp distress, fever, tachypnea, confusion, or agitation
● Complications:
○ Shock and respiratory failure esp in the elderly
○ Atelectasis
○ Pleural Effusion
○ Empyema = thick purulent fluid accumulated in pleural space
■ Treat with chest tube to drain fluid and 4-6 weeks of antibiotics
● Assessment & Dx:
○ ABG
○ Chest x-rays = shows abnormal density; no clinical way to differentiate bacterial and viral cause
○ Blood and sputum cultures
■ Take sputum early in morning
○ Auscultation = crackles, rales, wheezes, rhonchi, pleural friction rub
● Prevention/Interventions:
○ Promote coughing and expectoration of secretions. Encourage smoking cessation
○ Reposition frequently and promote lung expansion exercises and coughing
○ Oral hygiene
○ Elevate head of bed 30 degrees for pt’s in supine position who can’t protect airway
○ Fluids to liquefy secretions and replace insensible fluid loss from tachypnea and fever
■ 2-3 L a day; caution with elderly for fluid overload
○ Monitor and record intake and output
○ Postural drainage
○ Provide suction
○ Promote rest
○ Incentive spirometer
○ Vaccinations:
■ Pneumococcal pneumonia (Pneumovax, Prevnar, PCV)
● Every 5-7 years in healthy adults
● Pneumococcal (against streptococcal pneumoniae) vaccine lasts for 5 or more years
■ H influenza (Hib)
■ Influenza flu vaccine yearly
● Treatment/Management:
○ Antibiotics
○ For Viral Pneumonia:
■ Supportive only; don’t treat with antibiotics as it ↑ risk of resistance
■ Only use antibiotic with a viral infection when a secondary bacterial pneumonia, bronchitis, or sinusitis is present
■ Influenza Infection - antivirals
● Ex: Amantadine (symmetrel) and rimantadine
● Within 24 hrs of onset of infection
● Helps reduce symptoms and complications
● Best used with the flu vaccine
○ Analgesics
○ Antipyretics
○ Antitussives
■ Antihistamines to reduce sneezing and rhinorrhea
○ Bronchodilators: metaproterenol (Alupent), isoetharine (Brokosol), albuterol (Proventil)
✰​ Pulmonary Tuberculosis ​= ​Infectious disease that primarily affects the lung parenchyma (tissue)
❖ Airborne, infectious, communicable disease caused by Mycobacterium tuberculosis
❖ Airborne via droplet to alveoli and lung lobes via talking, coughing, sneezing, laughing, singing, etc.
➢ may be transmitted to other parts of the body, including meninges, kidneys, bones and lymph nodes.
❖ Initial Infection occurs 2-10 weeks after exposure
❖ not everyone infected with M. tuberculosis becomes sick.
➢ Latent TB infection = bacteria can live in body without making you sick. No symptoms, can become TB disease later on.
❖ Closely associated with poverty, malnutrition, overcrowding, substandard housing, and inadequate health care.

● Risk Factors:
○ Close and prolonged contact with someone who has active TB
○ Immunocompromised pt (ex: HIV, cancer, transplanted organs, prolonged high dose corticosteroid therapy)
○ Substance abuse (IV/injection drug users and alcoholics)
○ Any person without adequate health care
○ Pre Existing conditions (ex: diabetes, chronic kidney injury, malnourishment, selected malignancies, hemodialysis, transplanted organ)
○ Healthcare workers
○ Living in overcrowding, substandard housing
● Symptoms:
○ Maybe asymptomatic
○ Persistent cough (lasts 3 or more weeks)
■ Nonproductive
■ OR mucopurulent sputum or hemoptysis (blood) and copious secretions
○ Low grade fever
○ Night sweats
○ Fatigue
○ Weight loss
○ Failure to gain weight
○ Anorexia
○ Malnutrition
○ Crackles, wheezing
○ Diminished breath sounds
○ Enlarged painful lymph nodes
○ Fremitus = chest vibration with palpation
● Assessment & Dx:
○ Tuberculin Skin Test (Mantoux Test/PPD)​ = used to
determine whether a person has been infected with active or
latent TB
■ Tubercle bacillus extract is injected into the intradermal layer of the inner aspect of the forearm, approximately 4 inches below the
elbow.
■ Result is ready and read after 48-72 hours
■ Look for both redness and induration
● Erythema without induration is ​not​ considered significant
● Size of induration is significant and determines if person has TB
○ > 5 mm = is significant in pt’s with HIV, close contact with TB, other high risk pt
○ > 10 mm = significant in pt’s who have normal or mildly impaired immunity
■ Significant reaction = indicates past exposure to M. tuberculosis or vaccination with bacille Calmette-Guerin (BCG) vaccine
● Vaccine is given to produce greater resistance to development of TB
■ In older adults, it may not produce a reaction or it can be delayed for up to 1 week
● Second skin test is performed in 1-2 weeks
○ TB Blood Tests (QuantiFERON-TB Gold and T-Spot)​ = test for BCG vaccine
■ Results are available 24-36 hours
■ Positive IGRA (blood test) needs additional tests
○ Sputum culture​ = done to confirm dx
○ Chest X-ray = confirms presence of pulmonary TB
○ Gastric Washings = in children under 12 years because they don’t produce sputum.
■ Early morning after overnight fast
■ 3 consecutive days confirms positive pulmonary TB
● Prevention/Interventions:
○ Fluids to liquefy secretions and promote airway clearance
○ Small frequent feeding due to fatigue and debilitated state
○ Progressive activity and muscle strengthening
○ Oral care
○ Postural drainage
○ Make sure pt is adhering to prescribed treatment regimen
○ Educate importance of hygiene, covering mouth and nose when sneezing, coughing, etc.
○ Diet high in carb, proteins
● Treatment/Management:
○ Emphasize importance of takin meds on empty stomach or 1 hour before meals
○ Teach pt about risk of drug resistance if medication regimen isn’t followed
○ TB must be treated for at least 6 to 9 months. Several drugs must be used to treat TB disease.
○ First-Line Meds for Active TB: ​(multiple medication regimen)
■ Isoniazid (INH)
● Route​ = PO/IM daily for 9 months
● S&S ​= hepatotoxicity, flu like symptoms, neuropathy, hypersensitivity
● Considerations​:
○ Give pyridoxine (Vit B6) = to prevent/decrease peripheral neuropathy (tingling and numbness in fingers/toes
■ INH ↓
○ Monitor AST and ALT
○ Should​ avoid ​foods that contain: tyramine and histamine
■ Ex: tuna, aged cheese, red wine, soy sauce, yeast extracts
■ This is because it can cause headache, flushing, hypotension, lightheadedness, palpitations, and
diaphoresis
■ Rifampin
● Combinations:​ Rifamate (INH + rifampin)
● Route:​ PO/IV; PO daily for 4 months
● S&S:
○ Orange discoloration of urine ​(expected) and other secretions
○ Nausea and vomiting
○ Hepatitis
○ Sun sensitivity
○ Febrile reaction
○ Purpura (rare)
○ ↓ levels of many drugs
○ ↑ metabolism of oral contraceptives, corticosteroids, coumadin, digoxin, and oral hypoglycemic
● Monitor AST and ALT
● Considerations:
○ makes ​birth control pills and implants less effective.
■ Women who take rifampin should use another form of birth control.
○ can cause withdrawal symptoms for pt taking methadone (used to treat drug addiction).
■ Persons who take rifampin and methadone may need their methadone dosages adjusted.
○ can alter the metabolism of certain other medications, making them less effective.
■ Beta-blockers, oral contraceptives
○ Can ​discolor contact lenses​ = tell pt to wear eyeglasses during treatment
■ Pyrazinamide
● Route:​ PO for 8 weeks
● S&S:
○ Hepatotoxicity
○ hyperuricemia
○ Arthralgia
○ Skin rash
○ GI irritation
● Monitor uric acid, AST, ALT
● Considerations:
○ caution in patients who are diabetics, have kidney problems, or gout (bc the med increases uric acid levels)
■ Ethambutol
● Route: PO, 2x weekly
● S&S:
○ Optic neuritis
○ ↓ visual acuity
■ Report any blurred or color change
■ Always assess pt’s vision
○ Impaired red-green color discrimination
○ May lead to blindness
○ Skin rash
■ S&S to watch for all drugs:
● Hepatitis, hearing loss, rash
● Monitor BUN and creatinine
■ Streptomycin
● Route:​ IM, 2x weekly
● S&S​: ototoxicity, nephrotoxicity, hypokalemia
✰​ Pleural Effusion ​=​ Collection of fluid in the pleural space.
❖ Normally, the pleural space contains small amount which acts as a lubricant and allows pleural surfaces to move without friction
❖ Rarely a primary disease process, usually secondary to other diseases
➢ CHF, TB, pneumonia, pulmonary infections
❖ Fluids can be clear (transudate or exudate), bloody, or purulent
➢ Transudate = usually implies pleural membranes are not diseased
■ Most common from CHF
➢ Exudate = from inflammation by bacterial products or tumors involving pleural surfaces

● Symptoms:
○ Caused by underlying disease:
■ Pneumonia = fever, chills, pleuritic chest pain
■ Malignant effusion = dyspnea, difficulty lying flat, coughing
○ Severity of symptoms determined by size of effusion, speed of its formation,
and underlying lung disease:
■ Large pleural effusion = dyspnea, acute respiratory distress with
trachea deviating away from affected side
■ Small to moderate = minimal or no dyspnea
● Assessment & Dx:
○ ↓ or absent breath sounds
○ ↓ fremitus (vibration intensity felt on chest wall)
○ Dull, flat sound on percussion
○ Chest x-ray
○ AFT stain (for TB)
○ RBC & WBC count
○ Pleural biopsy
● Prevention/Interventions:
○ Prep pt for thoracentesis
■ Record amount/characteristics drained and send for lab testing
○ Monitor chest tube drainage and water-seal and record amount as prescribed in intervals
○ Care for underlying cause
○ Pain management
○ Educate pt and family about management and care of catheter and drainage system
● Treatment/Management:
○ Treat underlying cause (HF, pneumonia, cirrhosis)
○ Prevent reaccumulation of fluid
○ Relieve discomfort, dyspnea, and respiratory compromise
○ Thoracentesis = needle inserted into pleural space to remove excess fluid
○ Chest tube connected to water-seal drainage system or suction to evacuate pleural space and expand lung
○ If underlying cause is a malignancy, effusion tends to recur within a few days or weeks
■ Once pleural space is drained, a chemical pleurodesis may be performed to obliterate the pleural space and prevent re-accumulation
of fluid
● Pleurodesis = process of instilling a chemically irritating agent into pleural space to promote formation of adhesions
between visceral and parietal pleura
■ Surgical pleurectomy = insertion of small catheter attached to drainage bottle for outpatient management
■ Pleuroperitoneal shunt = 2 catheters connected by a pump chamber containing 2 one-way valves
● Fluid moves from pleural space to pump chamber and then to peritoneal cavity
● Pt manually pumps on reservoir daily to move fluid from pleural space to peritoneal space

✰​ Pleurisy (pleuritis) ​=​ inflammation of both layers of pleurae (parietal and visceral)
❖ Can develop due to PNA or upper resp tract infection, TB, chest trauma, after a thoracotomy and PE
❖ Pain worsens on inspiration, with coughing, and or sneezing

● Assessment & Dx:


○ Pleural friction rub
○ Sputum analysis
○ thoracentesis
● Prevention/Interventions:
○ Enhance comfort: turn the patient on the affected side to splint the chest wall to prevent stretching of the pleura.
○ Use pillow to splint the rib cage while coughing
● Treatment/Management:
○ Administration of analgesics, heat/cold, NSAIDs
○ Monitor for S&S of pleural effusion
✰​ Empyema ​=​accumulation of thick, purulent fluid within the pleural space.
❖ Occurs as complication of bacterial PNA or lung abscess

● S&S:
○ Pt is acutely ill and has S&S similar to acute respiratory infection or PNA
■ fever, night sweats, pleural pain, cough, dyspnea, anorexia, weight loss
● Assessment & Dx:
○ decreased/absent breath sounds
○ Dullness on chest percussion
● Prevention/Interventions:
○ Lung expansion exercises
○ Assist in drainage removal
● Treatment/Management:
○ Drain pleural cavity to complete expansion of lung
○ Antibiotics are administered in large doses (4-6 weeks)

✰​ Pulmonary Embolism ​=​ obstruction of the pulmonary artery or one of its branches by a thrombus (or thrombi)
that originates somewhere in the venous system or in the right side of the heart.
❖ Venous thromboembolism (VTE) includes both DVT (thrombus form in calf, thigh, arm) and PE.
❖ PE is commonly due to blood clot, air, fat, amniotic fluid, and septic
❖ Associated with trauma, surgery, pregnancy, HF, 50+ years, prolonged immobility

● S&S:
○ Dyspnea (most frequent symptom) • Diaphoresis
○ Sudden chest pain • Hemoptysis
○ Substernal pain (mimic angina pectoris or a MI) • Syncope
○ Fever • Tachypnea (most frequent sign)
○ Tachycardia • Rapid and weak pul\se
○ Cough • Anxiety
○ Shock • Swollen leg
● Assessment & Dx:
○ Death from acute PE commonly occurs within ​1 hour after​ onset of symptoms
■ Early recognition is a MUST
○ Chest x-ray = may show infiltrates, atelectasis, elevation of diaphragm on affected side, or pleural effusion
○ ECG = abnormal with sinus tachycardia; peaked P waves; inverted T waves
○ Pulse ox
○ ABG = hypoxemia and hypocapnia (from tachypnea) or it can be normal
○ Ventilation-Perfusion scan (V/Q) = use a contrast agent that evaluates different regions of lung and allows comparisons of the % of V/Q in each
area
○ Multidetector-row computed tomography angiography (MDCTA) = provides advantage of high quality visualization of lung cellular tissues
○ D-dimer = blood test for evidence of blood clots
■ Normal d-dimer, PE is ruled out
○ Pulmonary angiography = allows direct visualization under fluoroscopy of arterial obstruction and accurate assessment of perfusion deficit
● Prevention/Interventions:
○ Active and passive leg exercises to avoid venous stasis
○ Legs should not dangle; should rest on floor or chair
○ Early ambulation
○ Anti-embolism stockings
○ Elevate leg
○ IV catheters shouldn’t be left for prolonged periods
○ Semi-fowler position = for chest pain, however turn pt’s frequently
○ Oxygen therapy
○ Relieve anxiety
● Treatment/Management:
○ EMERGENCY management:
■ Give nasal oxygen = relieve hypoxemia, resp distress, and central cyanosis
■ Endotracheal intubation = for severe hypoxemia
■ Mechanical ventilator support
■ IV infusion lines
● Hypotension ont resolved by fluids = give vasopressor therapy (dobutamine, dopamine, norepinephrine)
■ Pulse ox/ABG/MDCTA
■ ECG = monitor dysrhythmias and right ventricular failure
■ Blood draw = F&E, CBC, coagulation studies
■ Urinary catheter = if massive emboli to monitor I&O
■ IV morphine/sedatives = for pt anxiety, chest pain, and improve tolerances to chest tube
○ Pharmacologic Management​:
■ Anticoagulation Therapy
● Immediately given to pt is suspected of PE
● Initial anticoagulant:
○ Low molecular weight heparin ​(enoxaparin = Lovenox)
■ Initial, but not long term
● Long term indicated from 10 days to 3 months following PE or indefinitely for pt’s who are high risk for recurrence
● Give warfarin for long term therapy
○ Monitor INR
○ Have Vit K available and if risk of bleeding
■ Thrombolytic Therapy:
● Used in pts with acute PE who have hypotension and don’t have a contraindication or potential bleeding risk
● Obtain INR, PTT, hematocrit, and platelet counts first
● Anticoagulant is stopped prior to administration of a thrombolytic agent
● Fresh whole blood, packed RBC, or frozen plasma is given to replace blood loss
● After thrombolytic infusion is completed, maintenance anticoagulation therapy is initiated
● Contraindications:
○ Stroke within past 2 months
○ Active bleeding
○ Active intracranial processes
○ Surgery within 10 days of thrombotic event
○ Recent labor or delivery, trauma, or severe hypertension
■ Surgical Management:
● Embolectomy = can be performed using catheters or surgically
○ Pt needs to be on cardiopulmonary bypass with a cardiovascular surgical team
○ Monitor pulmonary arterial pressure and urinary output
○ Assess insertion site for hematoma and infection
○ Maintain BP
● Inferior Vena Cava (IVC) Filter = filter provided a screen in the IVC allowing blood to pass through while large emboli
from pelvis or lower extremities are blocked or fragmented before reaching lung
○ Last resort

✰​ Lung Cancer ​=​ Most common cause of lung cancer is inhaled carcinogens, most often cigarette smoke (> 85%);
other carcinogens include radon gas and occupational and environmental agents.
❖ Lung cancer can metastasis to the bone, brain, adrenal gland, or liver
❖ Small Lung Cancer = 15% of tumors; small cell and combined small cell
❖ Non-small Lung Cancer (NSCLC) = 85% of tumors, squamous cell,
➢ Stages:
■ Stage I = earliest and has ↑ cure rate; localized in lung
■ Stage II = lung and localized in lymph nodes
■ Stage III = spread throughout lung, lymph nodes, and/or opposite lung
■ Stage IV = metastatic spread; both lungs, surrounding tissues and/or distant organ

● Risk Factors:
○ Environmental
■ tobacco, secondhand smoke, e-cigs
■ environmental and occupational exposures
● Pollutants, motor vehicle emissions, radon, arsenic, asbestos, etc)
■ Genetic predisposition
■ Dietary deficits
■ Underlying respiratory diseases (COPD, TB)
● S&S:
○ Develops gradually and is asymptomatic until late in its course
○ S&S depends on location and size of tumor, degree of obstruction, and existence of metastases to regional or distant sites
○ Common sites of metastases:
■ Lymph nodes, bone, brain, adrenal glands, liver, and contralateral lung
○ Most frequent​:
■ Cough or ​change in chronic cough
■ Cough may be dry, persistent, without sputum production
○ Early Signs​:
■ Recurring fever
■ dyspnea
○ Late Signs​:
■ Tight chest or shoulder pain
■ Neck swelling
■ Pleural effusion
○ Other Signs​:
■ Hemoptysis
■ Hoarseness, dysphagia, head and neck edema
■ Weight loss, anorexia
■ Bronchospasms = wheezing with partial obstruction by tumor
■ Fatigue = related to treatments
● Assessment & Dx:
○ Chest x-ray = for pulmonary density, atelectasis, pulmonary nodule and induction
○ Sputum specimen = for cytological exam
■ First morning sputum for presence of malignant cells
○ Bronchoscopy = visualize and obtain tissue for biopsy
○ CT scan & MRI = identify small nodules and the brain for CNS metastases
○ Fiberoptic bronchoscopy = provides detailed study of tracheobronchial tree
○ Transthoracic fine-needle aspiration = to aspirate cells from suspicious area
○ PET scan and liver ultrasound = to assess for metastasis of cancer
○ CBC, liver function studies = electrolytes (CALCIUM), evidence of metastasis
● Prevention/Interventions:
○ Address physiologic (resp manifestations of disease) and psychological needs of
pt
○ Ensure pain relief and discomfort to prevent complications
○ educate pt and family about potential side effects of treatments and strategies to
manage them
○ Airway clearance techniques:
■ Deep breathing
■ Chest physiotherapy
■ Directed cough
■ Suctioning
■ Bronchoscopy
■ Supplemental O2
■ Semi-fowler
○ Reduce fatigue
○ Provide psychological support
● Treatment/Management:
○ Surgery Resection​:
■ Recommended for localized NSCLC
■ Lobectomy = single lobe of lung is removed
■ Bilobectomy = 2 lobes of lung are removed
■ Sleeve Resection = cancerous lobe (s) is removed and segment of main bronchus is resected
■ Pneumonectomy = removal of entire lung
■ Segmentectomy = segment of lung is removed
■ Wedge resection = removal of small, pie-shaped area of segment
■ Chest wall resection = removal of cancerous lung tissue; for cancers that have invaded chest wall
○ Radiation Therapy​:
■ Controls neoplasms that can’t be surgically resected
■ Reduce tumor size in order to operate or relieve pressure on vita structures
■ Radiation is toxic to normal tissue and may lead to complications
■ Can relieve:
● Cough • hemoptysis
● Chest pain • bone and liver pain
● dyspnea
○ Chemotherapy​:
■ Alter tumor growth patterns, treat distant metastases or SCLC, and as an adjunct to surgery or radiation therapy
■ Provides relief but doesn’t cure
■ S&S/Monitor:
● Hair loss • monitor hypoxemia
● Monitor breathing patterns • sleep disturbances
● Poor nutrition • Reduce fatigue caused by pain/discomfort
● Anemia
○ Palliative therapy​:
■ To shrink tumor to provide pain relief
✰​ Pneumothorax ​=​ Parietal or visceral pleura are breached (opened) and the pleural space is exposed
to positive atmospheric pressure and the lung collapses. Free air enter the pleural space)

● Types:
○ Simple or Spontaneous​ = air enters the pleural space through an
opening in the visceral or parietal pleura
■ Can occur in healthy lung tissue due to a rupture of an
air-filled bleb (small air blisters which can burst
allowing air to leak into space that surrounds lungs))
or with COPD or emphysema
○ Traumatic​ = laceration in lung or trauma wound to chest wall
(ex: rib fracture, stabbing, subclavian line, thoracentesis,
mechanical ventilation)
■ Commonly associated with hemothorax = blood in
pleural space
■ Hemopneumothorax = both blood and air
○ Open pneumothorax = form of traumatic, occurs when chest
wound is large enough to allow air to pass freely in and out of
thoracic cavity with each respiration
■ Rush of air produces sucking sound
■ Emergency interventions
○ Tension Pneumothorax ​= complication of pneumothorax
■ Air enters lung from a wound in chest wall or
lacerated wall
■ Air that enters with each inspiration is trapped and
can’t be expelled during expiration through the wound
in chest
■ A one way valve is formed where air enters pleural
space but can’t escape
■ With each breath, tension ↑ in the pleural space
causing lung to collapse and the heart, great vessels,
and trachea to shift toward the unaffected side
● Causes ↓ venous return and CO
● Symptoms:​ hypoxemia, agitation,
hypotension, tachycardia, shock
● Treat:​ Oxygen and immediately decompress with a large bore ( 14 gauge ) followed by a chest tube
● S&S:
○ May have only minimal resp. distress
○ Lung may totally collapse with large pneumothorax causing severe resp distress = air hunger
○ See symptoms of tension pneumothorax
○ ↓ movement of affected side of chest wall
○ ↓ breath sounds
○ Tachypnea, SOB
○ Use of accessory muscles
○ Sudden or gradual onset of pain; sharp pain
○ Anxiety
○ Can develop central cyanosis from severe hypoxemia
● Assessment & Dx:
○ Chest x ray = air or blood in pleural space
○ Auscultation
○ CT scan
● Prevention/Interventions:
○ Bed rest
○ Oxygen supplementation
● Treatment/Management:
○ Insert Chest Tube = evacuate air, blood from pleural space
○ For open sucking traumatic chest wounds = stop flow of air through wound
■ Use towel, handkerchief, or heel of hand, Vaseline gauze pad with pressure dressing until chest tube is inserted
○ Thoracentresis = needle aspiration
✰​ Cardiac Tamponade ​=​ compression of the heart resulting from fluid or blood within the pericardial sac
❖ may follow diagnostic cardiac catheterization, angiographic procedures, and pacemaker insertion = can perforate the heart and great vessels

● Causes:
○ Blunt or penetrating trauma to chest
■ A penetrating wound of the heart is associated with a high mortality rate
● Symptoms:
○ Acute:
■ Chest pain • JVD
■ Tachypnea, dyspnea • Feeling of pressure in chest
■ Muted heart sound • hypotension
○ With hypotension pt can develop pulses paradoxus = a systolic BP that is lower during
inhalation
■ Characterized by abnormal difference of at least 10 mm Hg in systolic pressure
between point that is heard during exhalation and that is heard during inhalation
● Assessment & Dx:
○ Echocardiogram = confirm dx and quantify amount of pericardial fluid
○ Chest x-ray = show enlarged cardiac silhouette due to pericardial effusion
○ ECG = tachycardia and low voltage
● Treatment/Management:
○ Pericardiocentesis​ = puncture of pericardial sac to aspirate pericardial fluid
■ Pt is monitored by continuous ECG and frequent VS
■ Relieved cardiac tamponade is indicated with:
● ↓ in CVP and associated ↑ in BP after withdrawal of pericardial fluid
● Pt almost always feels immediate relief
■ Complications:
● Coronary artery puncture, myocardial trauma, dysrhythmias, pleural
laceration, and gastric puncture
■ Monitor: HR, BP, venous pressure, and heart sounds after performing
○ Pericardiotomy​ = open surgical drainage (last resort)
■ For recurrent pericardial effusions
■ With general anesthesia, a portion of the pericardium is excised to permit the exudative pericardial fluid to drain into lymphatic
system

✰​ SubQ Emphysema ​=​ results after chest trauma when lung or air passages are injured
● Air gets into tissues under skin
● Usually occurs in skin covering the chest wall or neck, but can also occur in other parts of the body
● Often can be seen as a smooth bulging of the skin
● When palpated, the skin produces an unusual crackling sensation as the gas is pushed through the tissue
○ This gives an alarming appearance as the face, neck, body and scrotum become misshapen by sucq air
● For severe cases a tracheostomy is indicated if airway patency is threatened by pressure of the trapped air in the trachea
✰​ Chronic Bronchitis ​=​ disease of the airways; excessive bronchial mucus secretion and cough for at least 3 months in 2 consecutive years
❖ Pt develops narrowed airways, impaired ciliary function, recurrent infection, pulmonary HPT, right-sided heart failure

● Factors:
○ Inflammation and ↑ airway mucus secretion​:
■ Smoke and environmental pollutants
■ Constant irritation = causes gland and goblet cells to ↑ in number which ↑ mucus
production
○ Bronchial walls thicken​:
■ Narrowing occurs of bronchial lumen
■ Pt becomes susceptible to respiratory infection which can produce acute episodes
of bronchitis
● Exacerbation most likely to occur in winter
● Symptoms:
○ Dyspnea
○ Cyanosis
○ Prolonged expiration
○ Scattered crackles, rhonchi, and wheezing
○ Cardiac dysrhythmias
○ ↑ mucus production
○ Chronic, productive cough
○ ↑ anterior-posterior diameter
○ Peripheral edema
○ Respiratory acidosis
○ Evidence of right-sided heart failure:
■ Neck vein distention, edema, liver engorgement, enlarged heart
✰​ Emphysema ​=​ Characterized by destruction of alveolar walls from overdistended alveoli
❖ Progresses slowly for many years
❖ As walls of alveoli are destroyed = alveolar surface area in direct contact with pulmonary capillaries continually ↓. This causes:
➢ an ↑ in dead space = no gas exchange occurs
➢ Impaired O2 diffusion = leads to hypoxemia
❖ In later stage, CO2 elimination is impaired. This results in:
➢ ↑ CO2 tension in arterial blood (hypercapnia) = leads to respiratory acidosis

● Tyes:
○ Panlobular = destruction on respiratory bronchiole, alveolar duct, and alveolus
■ All airspaces within lobule are enlarge, but there is little inflammatory disease
■ Hyperinflated chest, marked dyspnea on exertion, and adequate level of positive
pressure must be attained and maintained during expiration
■ Expiration becomes active and requires muscular effort
○ Centrilobular = changes take place mainly in center of secondary lobule
■ There is a derangement of ventilation-perfusion ratios
■ Produces chronic hypoxemia, hypercapnia, polycythemia (↑ in RBC), and
episodes of right-sided heart failure
■ This leads to central cyanosis and respiratory failure
■ Pt also develops peripheral edema
● Symptoms:
○ Dyspnea pm exertion (gradual onset) which progresses to severe at rest
○ Barrel chest​ = due to loss of chest elasticity causing ribs to become rigid and fixed in
inspiratory position
○ Use of accessory muscles
○ ↑ AP diameter of chest (1:1)
○ ↓ breath sounds with expiratory wheezes
○ SOB
○ Weight loss (from breathing)
○ Pt may​ look “pink and puffy”
○ Tachypnea
○ Leans forward while sitting
○ Breathing through pursed lips
○ Fatigue
○ absent or decreased breath sounds, possible crackles, wheezes, or rhonchi

✰​ COPD ​=​ Chronic obstructive pulmonary disease is a group of conditions causing the chronic or recurrent obstruction of airflow.
❖ Can result from the combination of symptoms associated with: ​1) ​chronic bronchitis ​2.)​ emphysema and ​3)​ asthma
❖ Pt’s with COPD commonly become symptomatic during the middle adult years which ↑ in incidence with age
❖ It if progressive and associated with the lungs abnormal inflammatory response to noxious particles or gases

● Risk Factors:
○ Exposure to tobacco smoke and secondhand smoke (passive)
○ ↑ age
○ Occupational exposure - dust, chemicals
○ Indoor and outdoor air pollution
○ Genetic abnormalities including:
■ Deficiency of alpha=antitrypsin, an enzyme inhibitor that normally
counteracts the destruction of lung tissue by certain other enzymes
○ Allergies and recent pulmonary infection
● Assessment & Dx:
○ Pulmonary function tests
○ Serum alpha-antitrypsin level = screen for deficiency
○ ABG = ↓pao2; ↑pco2
○ Spirometry
○ CBC with differential /↑ RBCs and hematocrit
■ Due to chronic hypoxia
○ ↑ WBC with infection
○ Chest x-rays = shows flattening of diaphragm due to hyperinflation, presence
of infection.
○ Bronchodilator Reversibility Testing​ = to rule out asthma (acute) vs chronic bronchospasms
■ Spirometry obtained first
■ Then inhale bronchodilator
■ Then repeat spirometry
■ Indicates it’s reversible if pt improves after treatment
○ Peak Expiratory Flow Rate = will measure expiratory ability and help assess condition improvement after treatment
● Treatment/Management:
○ Stop smoking; nicotine therapy
○ Remain inside during times of significant air pollution; air filters and air conditioning
○ When dusting, use a wet cloth
○ Percussion and postural drainage
○ Avoiding cough suppressants and sedation
○ Regular exercise program
○ Changing eating habits so he or she eats small, frequent meals rather than large meals
■ High calorie, high protein
○ Request referral to pulmonary rehabilitation and encourage patients to learn how to improve activity tolerance and perform ADLs with less
dyspnea
○ Breathing exercises to slow respiratory rate and relieve accessory muscle fatigue
■ Pursed-lip breathing = slow expiration and prevent collapse of small airways and improve alveolar ventilation by expelling as much
air as possible, ↓ air trapping
■ Inspiratory muscle breathing against resistance
● Conditioned muscles use less O2
■ Directed “huff” coughing
■ Incentive spirometer
■ Deep breathing exercises
○ Hydration = Saline or water aerosol mists
○ Avoid temperature extremes = heat ↑ body temp, raising O2 needs; cold promotes bronchospasm
○ Inhalation = route of choice because it allows for topical relief and acts quickly
■ Ex: MDI, spacers
○ Oxygen Supplementation​:
■ Pt with COPD who is CO2 retainer responds to ↓ levels of O2 as stimulus to breathe
■ Giving high flow rates of O2 will ​↓ all stimulus to breathe and ↑ CO2
● ***Use with caution!
● low flow rate recommended​ (​1-2 L/min​)
■ Long term therapy used for severe, progressive hypoxemia
■ Indications for O2 therapy are PaO2 of 55 or less
■ Goal is to keep SpO2 >90%
○ Medications​:
■ Bronchodilators → corticosteroids →mucolytics
■ Bronchodilators = reduce airway obstruction, ↑ O2
■ Anti-inflammatory meds
● Ex: corticosteroids (used more in asthma than COPD)
■ Antibiotics PRN
■ Mucolytics
■ Antitussives
■ Vaccinations:
● Hib Vaccine
● Influenza vaccine = yearly
● Pneumococcal (PCV) = every 5-7 years
○ Surgery​:
■ Bullectomy = used for bullous emphysema
● Bullae may be surgically excised to reduce dyspnea and improve lung function

✰​ Asthma ​=​ Chronic disease characterized by reversible obstruction of airflow due to inflammation and narrowing of the airways.
❖ Causes airway hyperresponsiveness, mucosal edema, and mucus production
❖ Inflammation leads to = recurrent episodes of asthme
➢ Cough, chest tightness, wheezing, and dyspnea
❖ Acute and can be chronic and is largely reversible, either spontaneously or with treatment
❖ Most often at night or early morning
❖ Initially: hypocapnia and respiratory alkalosis because breathing very rapidly
❖ May be symptom free with exacerbations lasting minutes to days

● Risk Factors:
○ Allergy = Chronic exposure to airway irritants ↑ risk
■ Seasonal: grass, tree, weed pollen
■ Perennial: mold, dust, roaches, animal dander
○ Air pollutants • Cold, heat, weather changes
○ Strong odors or perfumes • Smoke and occupational exposure
○ Foods, exercise, stress, hormonal factors • Medications, viral resp tract infections, GERD
● Symptoms:
○ Asthma attacks often occur at night or early in morning
○ Cough (with or without mucus production) • tachycardia
○ Dyspnea • widened pulse pressure
○ Wheezing (first on expiration, then inspiration) • hypoxemia/central cyanosis (late sign)
○ Prolonged expiratory time • airway “remodeling” in chronic inflammation
○ Chest tightness • ↓ SpO2
○ Diaphoresis • accessory muscle use
○ Tripod positioning • nasal flaring
● Assessment & Dx:
○ Peak Expiratory Flow Rate​ (PEFR) = maximal forced expiratory flow
■ Daily Peak Flow Monitoring - peak flow meter
(spirometer) measures ability to push air forcefully out of
the lungs.
■ Meds administration and effectiveness of treatment can be
based on peak expiratory flow rate (PEFR).
■ The “personal best” is determined after monitoring PERF
2-4 times per day for 2-3 weeks after receiving optimal
asthma therapy.
● Prevention/Interventions​:
○ Monitor VS
○ Monitor pulse ox and peak flow
○ During an acute episode: use interventions to assist with breathing
○ ↓ anxiety (stay with pt)
○ Administer meds = bronchodilators/corticosteroids
○ Record color, amount, and consistency of sputum if any
○ Auscultate lungs before during and after
○ Helpful breathing techniques
○ Position pt’s body for optimal air exchange
○ Assess for dehydration = administer IV fluids (check skin turgor for
dehydration and to loosen secretions)
○ Conservation of energy
○ Avoidance of triggers/respiratory irritants
○ Educate pt:
■ Smoking cessation
■ Important of exercise
■ Need to cough up sputum
● Treatment/Management:
○ Asthma Action Plan ​= based on peak flow measurements
■ Provides instruction on recognition of early S&S of
worsening asthma and self management:
● Green​ = 80-100% personal best
○ Breathing is good and pt is doing well
○ No coughing, wheeze, SOB, chest
tightness
○ Sleep through night
○ Can work and play
○ Action: use preventative meds
● Yellow​ = 50-80% personal best
○ Asthma is getting worse
○ Pt may have cough, wheezing, chest
tightness, SOB
○ May wake up at night due to asthma
○ Implement action plan
● Red ​= < 50% personal best
○ Indicates medical alert
○ Pt is very SOB
○ quick relief meds might not work
○ pt may not be able to do usual activities
○ Symptoms are same or get worse after
24 hours in yellow zone
○ Implement action plan and call MD if they don’t return to yellow or green
○ Fluids ​= pt is frequently dehydrated from diaphoresis and insensible fluid loss with hyperventilation
■ 2-4 L/day unless contraindicated
○ Oxygen PRN ​= keep pulse ox at > or - 92%
○ Medications​:
■ Quick relief meds = for immediate treatment of asthma symptoms and exacerbations
● First used to prompt relief of airflow obstruction
● Short acting beta 2 adrenergic agonists
● Anticholinergics
■ Long acting meds = to maintain control of persistent asthma
● Corticosteroids
● Long acting beta 2 adrenergic agonists
● Leukotrienes
■ immunomodulators
● Status Asthmaticus​ =asthma attack of such severity that it is considered a medical emergency. It can lead to respiratory failure and death.
○ Attacks last longer than 24 hours
○ Often precipitated by an upper respiratory infection, illicit drug use, an allergic reaction, exercising in cold weather, recent tapering of
corticosteroid use, or exposure to air pollution, mold, or dust.
○ Initially ABGs show hypoxemia and respiratory alkalosis with a ↓ CO2 from tachypnea
○ As they worsen, CO2 ↑ (**danger sign of impending resp failure as pt is becoming fatigued with slower respiration; pt may need a ventilator)
○ As obstruction worsens, the wheezing may disappear
○ S&S​:
■ Dyspnea, labored breathing ⬛ ​chest tightness
■ Prolonged exhalation ⬛ ​engorged neck veins
■ Wheezing ⬛ ​↑ mucous production
■ Dry cough ⬛ ​agitation/restlessness
■ Tachypnea ⬛ ​rapidly worsening SOB

✰​ Obstructive Sleep Apnea ​=​ characterized by recurrent episodes of upper airway obstruction and a reduction in ventilation.
❖ Defined as cessation of breathing (apnea) during sleep usually caused by repetitive upper airway obstruction
❖ Interferes with people’s ability to obtain adequate rest
❖ Affects = memory, learning, and decision making which results in hypoxia and hypercapnia

● Risk Factors:
○ Obesity
○ Male gender
○ Postmenopausal status
○ Advanced age
● Symptoms:
○ 3 S’s = snoring, sleepiness, and significant other report of sleep apnea
○ Loud snoring with breathing cessation for 10 sec or longer
■ At least 5 episode/hr followed by awakening abruptly with loud snort as the blood oxygen level drops
■ Often happens during REM stage of sleep
○ Excessive daytime sleepiness • frequent nocturnal awakening •polycythemia
○ Insomnia • morning headaches • enuresis
○ Intellectual deterioration • personality changes, irritability • dysrhythmias
○ Impotence • systemic hypertension • pulmonary hypertension, cor pulmonale
● Assessment & Dx:
○ Overnight study polysomnographic (sleep study​)
■ Performed in a specialized sleep disorders center which measures physiologic signals while pt sleeps
● Prevention/Interventions:
○ Weight loss
○ Positional therapy
○ Oral appliance = mandibular advancement devices (MADs)
○ CPAP/BiPAP severe cases
■ BiPAP = supplemental O2 therapy via nasal cannula and result in a lower average airway pressure
● Used with hypoxemia and severe hypercapnia
■ CPAP = used to prevent airway collapse
● Treatment/Management:
○ Meds​:
■ Modafinil (provigil) = reduce daytime sleepiness
■ Protryptilin (triptil) = at bedtime to ↑ resp drive and improve upper airway muscle tone
■ Not a substitute for CPAP and BiPAP
○ Surgical Management​:
■ Simple Tonsillectomy = effective for pt with large tonsils when other options have failed
■ Uvulopalathopharyngoplasty = resection of pharyngeal soft tissue and removal of 15 mm of free edge of soft palate and uvula
■ Tracheostomy = relieves upper airway obstruction
● Side Effect: speech difficulty and ↑ risk of infection

You might also like